The 2022 OncoAlert Colloquium Day 2: GU Oncology

Share :
Published: 31 Jan 2023
Views: 61
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

Dr Gilberto Morgan introduces the second day (24th January) of the 2022 OncoAlert Colloquium.

Day two of the Colloquium focusing on the best in GU Oncology 2022 and hosts the following key speakers:

Dr Gilberto Morgan of OncoAlert discussing 'FDA approvals in 2022 and corresponding trials'.

Dr Toni Choueiri (Dana Farber, Boston, USA) discussing 'Kidney Cancer'.

Dr Neeraj Agarwal (Huntsman Institute, Salt Lake City, USA) discussing 'Prostate Cancer'.

Dr Petros Grivas (University of Washington, Seattle, USA) discussing 'Bladder Cancer'.

Dr Sean McBride (Memorial Sloan Kettering, New York, USA) discussing 'GU Radiation Therapy on the ASTRO session'.

Mr Bryan Lewis (KidneyCan, USA) discussing 'The Patient Perspective in Kidney Cancer'.

Dr John Haanen (Netherlands Cancer Institute, Amsterdam, Netherlands) discussing 'Immuno Oncology in 2022'.

Finishing off with with a MASCC Session by Dr Florian Scotte (Gustave Roussy, Villejuif, France) discussing 'Targeted Therapy Toxicities'.